Assigned to APPROP                                                                                                             FOR COMMITTEE

 


 

 

 


ARIZONA STATE SENATE

Fifty-Fifth Legislature, Second Regular Session

 

FACT SHEET FOR s.b. 1715

 

hemp-derived manufactured cannabinoids; prohibition

Purpose

Defines hemp-derived manufactured psychotropic cannabinoids. Contains requirements for enactment for initiation and referendum (Proposition 105).

Background

The Smart and Safe Arizona Fund (Fund) consists of monies received from tax on the sale of recreational marijuana products and license and registration fees. Monies in the Fund are to be used to pay for costs to state agencies to implement 2020 Proposition 207. The remaining monies are distributed as follows: 1) 33 percent to community college districts; 2) 31.4 percent to municipal police and fire departments; 3) 25.4 percent to the Highway User Revenue Fund; 4) 10 percent to the Justice Reinvestment Fund; and 5) 0.2 percent to the Attorney General (A.R.S.
§ 36-2856
).

There is no anticipated fiscal impact to the state General Fund associated with this legislation.

Provisions

1.   Defines hemp-derived manufactured psychotropic cannabinoids as any cannabinoid that is derived from hemp and altered by a chemical reaction that changes the molecular structure of any natural cannabinoid derived from hemp to another cannabinoid with psychotropic properties that is found naturally in hemp that includes:

a)   delta-8 tetrahydrocannabinol;

b)   delta-10 tetrahydrocannabinol;

c)   hexahydrocannabinol;

d)   tetrahydrocannabiphoral;

e)   tetrahydrocannabinol acetate ester; and

f) tetrahydrocannabivarin.

2.   Excludes any cannabinoid derived from hemp that is produced by decarboxylation from naturally occurring cannabinoid acid without the use of a chemical catalyst from the definition hemp-derived manufactured psychotropic cannabinoids.

3.   Excludes hemp-derived manufactured psychotropic cannabinoids from the definitions of industrial hemp, usable marijuana, marijuana concentrate, marijuana products and marijuana.

4.   Adds investigating and acting on the sale, marketing and distribution of hemp-derived manufactured psychotropic cannabinoids to the allowable uses of the Attorney General's portion of the Fund monies.

5.   Makes technical and conforming changes.

6.   Requires for enactment the affirmative vote of at least three-fourths of the members of each house of the Legislature (Proposition 105).

7.   Becomes effective on the general effective date.

Prepared by Senate Research

February 4, 2022

LMM/sr